Salveen Richter
Stock Analyst at Goldman Sachs
(4.54)
# 998
Out of 4,517 analysts
504
Total ratings
48.2%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Buy | $250 | $204.50 | +22.25% | 31 | Jul 13, 2026 | |
| INCY Incyte | Maintained: Hold | $100 | $116.39 | -14.08% | 25 | Jul 13, 2026 | |
| IONS Ionis Pharmaceuticals | Maintained: Hold | $75 → $68 | $55.55 | +22.41% | 15 | Jul 9, 2026 | |
| ALNY Alnylam Pharmaceuticals | Maintained: Buy | $550 | $285.31 | +92.77% | 22 | Jun 25, 2026 | |
| MRNA Moderna | Maintained: Hold | $49 | $65.36 | -25.03% | 46 | Jun 25, 2026 | |
| QURE uniQure | Rated: Hold | $14 → $46 | $40.17 | +14.51% | 21 | Jun 17, 2026 | |
| AGIO Agios Pharmaceuticals | Maintained: Hold | $32 | $38.99 | -17.92% | 16 | Jun 14, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Sell | $9 | $12.15 | -25.93% | 17 | Jun 14, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $641 | $480.46 | +33.41% | 26 | Jun 10, 2026 | |
| APGE Apogee Therapeutics | Maintained: Hold | $89 | $134.19 | -33.68% | 2 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $425 → $389 | $367.95 | +5.72% | 20 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 | $52.71 | +11.93% | 5 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $19.40 | +13.40% | 11 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $24.36 | +68.31% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $968 | $678.80 | +42.60% | 23 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 | $22.82 | +53.41% | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $7 | $6.33 | +10.67% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $127 → $69 | $59.97 | +15.06% | 17 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $130 | $133.09 | -2.32% | 14 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 → $33 | $11.24 | +193.59% | 12 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $17.31 | -7.57% | 2 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41 | $14.50 | +182.76% | 3 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $32.32 | +54.70% | 1 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 | $40.03 | +27.40% | 2 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $26 | $13.67 | +90.20% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $61 → $25 | $30.69 | -18.54% | 12 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $6.10 | +80.48% | 5 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $17.56 | -3.19% | 23 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 | $27.01 | -40.76% | 6 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $15 → $17 | $26.07 | -34.79% | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $10.88 | +74.63% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $47 → $48 | $48.83 | -1.70% | 15 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 → $40 | $22.36 | n/a | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.51 | n/a | 9 | Dec 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $39 | $3.54 | n/a | 1 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $30 | $23.55 | n/a | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 → $5 | $22.58 | n/a | 8 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $82.27 | n/a | 1 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $59.90 | n/a | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $53 | $57.72 | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $7 | $2.92 | n/a | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $31 | $1.83 | n/a | 10 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $211.53 | n/a | 2 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $22 | $3.29 | n/a | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $7 | $14.21 | n/a | 2 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $8.46 | n/a | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 → $9 | $3.16 | n/a | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $34 → $6 | $3.42 | n/a | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $28 → $30 | $4.92 | n/a | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $126 → $131 | $542.71 | n/a | 7 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $11 | $2.68 | n/a | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $40 | $6.01 | n/a | 1 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $47 | $72.52 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $2 | $9.14 | n/a | 3 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $44 → $76 | $534.53 | n/a | 3 | Oct 29, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $18 → $2 | $3.64 | n/a | 2 | Oct 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $0.0001 | n/a | 1 | Dec 2, 2011 |
Biogen
Jul 13, 2026
Maintained: Buy
Price Target: $250
Current: $204.50
Upside: +22.25%
Incyte
Jul 13, 2026
Maintained: Hold
Price Target: $100
Current: $116.39
Upside: -14.08%
Ionis Pharmaceuticals
Jul 9, 2026
Maintained: Hold
Price Target: $75 → $68
Current: $55.55
Upside: +22.41%
Alnylam Pharmaceuticals
Jun 25, 2026
Maintained: Buy
Price Target: $550
Current: $285.31
Upside: +92.77%
Moderna
Jun 25, 2026
Maintained: Hold
Price Target: $49
Current: $65.36
Upside: -25.03%
uniQure
Jun 17, 2026
Rated: Hold
Price Target: $14 → $46
Current: $40.17
Upside: +14.51%
Agios Pharmaceuticals
Jun 14, 2026
Maintained: Hold
Price Target: $32
Current: $38.99
Upside: -17.92%
Intellia Therapeutics
Jun 14, 2026
Maintained: Sell
Price Target: $9
Current: $12.15
Upside: -25.93%
Vertex Pharmaceuticals
Jun 10, 2026
Maintained: Buy
Price Target: $641
Current: $480.46
Upside: +33.41%
Apogee Therapeutics
Jun 10, 2026
Maintained: Hold
Price Target: $89
Current: $134.19
Upside: -33.68%
Jun 5, 2026
Maintained: Buy
Price Target: $425 → $389
Current: $367.95
Upside: +5.72%
Jun 4, 2026
Maintained: Buy
Price Target: $59
Current: $52.71
Upside: +11.93%
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $19.40
Upside: +13.40%
Jun 1, 2026
Maintained: Buy
Price Target: $41
Current: $24.36
Upside: +68.31%
May 18, 2026
Maintained: Buy
Price Target: $968
Current: $678.80
Upside: +42.60%
May 13, 2026
Maintained: Buy
Price Target: $35
Current: $22.82
Upside: +53.41%
May 12, 2026
Initiated Coverage: Hold
Price Target: $7
Current: $6.33
Upside: +10.67%
May 11, 2026
Initiated Coverage: Hold
Price Target: $127 → $69
Current: $59.97
Upside: +15.06%
May 8, 2026
Maintained: Hold
Price Target: $130
Current: $133.09
Upside: -2.32%
May 8, 2026
Maintained: Buy
Price Target: $38 → $33
Current: $11.24
Upside: +193.59%
May 4, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $17.31
Upside: -7.57%
May 1, 2026
Maintained: Buy
Price Target: $41
Current: $14.50
Upside: +182.76%
Apr 30, 2026
Maintained: Buy
Price Target: $50
Current: $32.32
Upside: +54.70%
Apr 21, 2026
Maintained: Buy
Price Target: $51
Current: $40.03
Upside: +27.40%
Apr 9, 2026
Maintained: Buy
Price Target: $14 → $26
Current: $13.67
Upside: +90.20%
Mar 24, 2026
Downgraded: Hold
Price Target: $61 → $25
Current: $30.69
Upside: -18.54%
Mar 19, 2026
Maintained: Buy
Price Target: $11
Current: $6.10
Upside: +80.48%
Feb 25, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $17.56
Upside: -3.19%
Oct 30, 2025
Maintained: Hold
Price Target: $16
Current: $27.01
Upside: -40.76%
Aug 7, 2025
Maintained: Sell
Price Target: $15 → $17
Current: $26.07
Upside: -34.79%
Aug 7, 2025
Maintained: Hold
Price Target: $19
Current: $10.88
Upside: +74.63%
Aug 5, 2025
Maintained: Hold
Price Target: $47 → $48
Current: $48.83
Upside: -1.70%
Jan 28, 2025
Maintained: Buy
Price Target: $46 → $40
Current: $22.36
Upside: n/a
Dec 19, 2024
Rated: Hold
Price Target: n/a
Current: $8.51
Upside: n/a
Apr 2, 2024
Initiated Coverage: Hold
Price Target: $39
Current: $3.54
Upside: n/a
Mar 5, 2024
Maintained: Buy
Price Target: $37 → $30
Current: $23.55
Upside: n/a
Feb 16, 2024
Maintained: Hold
Price Target: $48 → $5
Current: $22.58
Upside: n/a
Jan 8, 2024
Maintained: Buy
Price Target: n/a
Current: $82.27
Upside: n/a
Jan 5, 2024
Maintained: Buy
Price Target: n/a
Current: $59.90
Upside: n/a
Jul 31, 2023
Maintained: Buy
Price Target: $53
Current: $57.72
Upside: n/a
Jun 12, 2023
Maintained: Sell
Price Target: $7
Current: $2.92
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $32 → $31
Current: $1.83
Upside: n/a
Feb 24, 2023
Maintained: Buy
Price Target: $225
Current: $211.53
Upside: n/a
Nov 14, 2022
Initiated Coverage: Hold
Price Target: $22
Current: $3.29
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: $30 → $7
Current: $14.21
Upside: n/a
Nov 10, 2022
Maintained: Hold
Price Target: $2 → $1
Current: $8.46
Upside: n/a
Nov 9, 2022
Maintained: Hold
Price Target: $8 → $9
Current: $3.16
Upside: n/a
Nov 3, 2022
Maintained: Hold
Price Target: $34 → $6
Current: $3.42
Upside: n/a
Mar 4, 2021
Upgraded: Buy
Price Target: $28 → $30
Current: $4.92
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $126 → $131
Current: $542.71
Upside: n/a
Nov 9, 2020
Maintained: Sell
Price Target: $11
Current: $2.68
Upside: n/a
Oct 28, 2020
Downgraded: Hold
Price Target: $40
Current: $6.01
Upside: n/a
May 8, 2020
Maintained: Hold
Price Target: $45 → $47
Current: $72.52
Upside: n/a
Nov 13, 2019
Maintained: Sell
Price Target: $4 → $2
Current: $9.14
Upside: n/a
Oct 29, 2013
Rated: Hold
Price Target: $44 → $76
Current: $534.53
Upside: n/a
Oct 15, 2013
Downgraded: Hold
Price Target: $18 → $2
Current: $3.64
Upside: n/a
Dec 2, 2011
Initiated Coverage: Buy
Price Target: $13
Current: $0.0001
Upside: n/a